IcoSema, a combination therapy of basal insulin icodec and semaglutide, achieves a noninferior reduction in A1c levels compared with basal-bolus therapy in adults with T2D.

The addition of anagliptin to insulin and metformin therapy may improve glycemic control in patients with type 2 diabetes while maintaining an acceptable safety profile.

For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with ...

Tara Eacobacci had an appointment with her doctor that was devoted exclusively to the topic of health insurance. A major ...

By all means, if you’ve been told that exercise is non-negotiable for diabetes management, you’ve heard right. But what they ...

Among adult patients with type 2 diabetes, CGM prescriptions less likely for those with non-English language preference.

The University of Cincinnati's Robert Cohen, MD, commented to MedCentral on two new studies presented at the American ...

The Grammy-nominated musicians discuss what's helping them manage, and why they’re using their platform to reach the Black ...

David Petrus IbarsIn the same way weight varies from person to person, so do the best weight loss strategies. While some ...